Arrivent Biopharma Inc (AVBP)

Investing Cash Flow

$46.07M

Quarterly · Period ending: · USD

AVBP logo

AVBP Investing Cash Flow

Latest reported$46.07M
AVBP Quarterly Cash from Investing ($0.00 → $46.07M)
High-resolution chart · PNG

AVBP investing cash flow history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Arrivent Biopharma Inc Investing Cash Flow — Quarterly (USD)
Period endingInvesting Cash Flow (USD)
46,072,000
3,582,000
-71,199,000
-50,760,000
13,910,000
36,821,000
-192,465,000
0
0
0
25,000,000
0
-25,000,000
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.